Asarina Pharma AB (publ) (ASAP.ST) Research

Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.

Market snapshot

Symbol
ASAP.ST
Price
$0.03
Day change
-31.03%
Market cap
$634.0K
P/E ratio
-0.05x
52-week range
0.028-1.315
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Ascelia Pharma AB (publ) (ACE.ST)
  • BioArctic AB (publ) (BIOA-B.ST)
  • Biovica International AB (publ) (BIOVIC-B.ST)
  • Cantargia AB (publ) (CANTA.ST)
  • Sprint Bioscience AB (publ) (SPRINT.ST)

Open Asarina Pharma AB (publ) (ASAP.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.